Screener
Mirum Pharmaceuticals, Inc. MIRM Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromConvertibleDebt.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-K, filed February 25, 2026. Open the filing →
- Filed
- Feb 25, 2026, 4:28 PM EST
- Fiscal year
- FY2025
- Accession
- 0001759425-26-000013
FAQ
- What is Mirum Pharmaceuticals, Inc.'s debt issuance proceeds?
- Mirum Pharmaceuticals, Inc. (MIRM) reported debt issuance proceeds of $0 in Q4 2025.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about Mirum Pharmaceuticals, Inc.'s debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude